| Literature DB >> 31101625 |
Wei Li1,2,3, Yaomei Wang1,2,4, Huizhi Zhao1, Huan Zhang1,2, Yuanlin Xu1,5, Shihui Wang1,2, Xinhua Guo2, Yumin Huang2,6, Shijie Zhang1, Yongshuai Han1, Xianfang Wu7, Charles M Rice7, Gang Huang8, Patrick G Gallagher9, Avital Mendelson10, Karina Yazdanbakhsh10, Jing Liu11, Lixiang Chen1, Xiuli An1,2.
Abstract
The erythroblastic island (EBI), composed of a central macrophage and surrounding erythroid cells, was the first hematopoietic niche discovered. The identity of EBI macrophages has thus far remained elusive. Given that Epo is essential for erythropoiesis and that Epor is expressed in numerous nonerythroid cells, we hypothesized that EBI macrophages express Epor so that Epo can act on both erythroid cells and EBI macrophages simultaneously to ensure efficient erythropoiesis. To test this notion, we used Epor-eGFPcre knockin mouse model. We show that in bone marrow (BM) and fetal liver, a subset of macrophages express Epor-eGFP. Imaging flow cytometry analyses revealed that >90% of native EBIs comprised F4/80+Epor-eGFP+ macrophages. Human fetal liver EBIs also comprised EPOR+ macrophages. Gene expression profiles of BM F4/80+Epor-eGFP+ macrophages suggest a specialized function in supporting erythropoiesis. Molecules known to be important for EBI macrophage function such as Vcam1, CD169, Mertk, and Dnase2α were highly expressed in F4/80+Epor-eGFP+ macrophages compared with F4/80+Epor-eGFP- macrophages. Key molecules involved in iron recycling were also highly expressed in BM F4/80+Epor-eGFP+ macrophages, suggesting that EBI macrophages may provide an iron source for erythropoiesis within this niche. Thus, we have characterized EBI macrophages in mouse and man. Our findings provide important resources for future studies of EBI macrophage function during normal as well as disordered erythropoiesis in hematologic diseases such as thalassemia, polycythemia vera, and myelodysplastic syndromes.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31101625 PMCID: PMC6676133 DOI: 10.1182/blood.2019000430
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113